Moderna, COVID-19
While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...
On Aug. 22, the U.S. Food and Drug Administration announced the approval of a new Novavax COVID vaccine, as well as updated ...
GSK secured the first US Food and Drug Administration (FDA) approval for an adult RSV vaccine in May 2023, called Arexvy.
The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...
With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...
Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...
Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...
For those who are uninsured or under-insured, CDPH will have vaccine at its three CDPH Immunization Clinics. Walk-ins are ...